Beliaeva, M.M.; Dzaurova, K.M.; Yuricheva, Y.A.; Novikov, P.S.; Mironov, N.Y.; Tarasovskiy, G.S.; Zelberg, M.A.; Sokolov, S.F.; Golitsyn, S.P.
Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure. J. Cardiovasc. Dev. Dis. 2023, 10, 487.
https://doi.org/10.3390/jcdd10120487
AMA Style
Beliaeva MM, Dzaurova KM, Yuricheva YA, Novikov PS, Mironov NY, Tarasovskiy GS, Zelberg MA, Sokolov SF, Golitsyn SP.
Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure. Journal of Cardiovascular Development and Disease. 2023; 10(12):487.
https://doi.org/10.3390/jcdd10120487
Chicago/Turabian Style
Beliaeva, Maria M., Khava M. Dzaurova, Yulia A. Yuricheva, Peter S. Novikov, Nikolay Yu. Mironov, Gennady S. Tarasovskiy, Maksim A. Zelberg, Sergey F. Sokolov, and Sergey P. Golitsyn.
2023. "Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure" Journal of Cardiovascular Development and Disease 10, no. 12: 487.
https://doi.org/10.3390/jcdd10120487
APA Style
Beliaeva, M. M., Dzaurova, K. M., Yuricheva, Y. A., Novikov, P. S., Mironov, N. Y., Tarasovskiy, G. S., Zelberg, M. A., Sokolov, S. F., & Golitsyn, S. P.
(2023). Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure. Journal of Cardiovascular Development and Disease, 10(12), 487.
https://doi.org/10.3390/jcdd10120487
